UFT adjuvant chemotherapy

DRUG2 trials

Sponsors

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Conditions

Colorectal Cancer

Phase 3

Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery

CompletedNCT00392899

Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanColorectal Cancer

Start: 2006-10-31End: 2016-09-30Updated: 2016-09-28

Unknown Phase

Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery

CompletedNCT00898846

Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanColorectal Cancer

Start: 2006-10-31End: 2016-09-30Updated: 2016-09-28

Related Papers

Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial

Journal of Clinical Oncology2019-06-10138 citations

Prognostic impact of MSI and 18qLOH in stage II colon cancer: A prospective biomarker study in the SACURA trial

Annals of Oncology2018-10-011 citations

A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur–uracil versus surgery alone in stage II colon cancer: SACURA trial

European Journal of Cancer2018-04-1781 citations

Prognostic impact of tumor budding in stage II colon cancer: A prospective study (SACURA trial).

Journal of Clinical Oncology2017-05-202 citations

Prognostic impact of MSI in stage II colon cancers: An additional translational study of the SACURA trial.

Journal of Clinical Oncology2017-05-202 citations

Recurrence risk factors and outcome stratification in stage II colon cancer patients: A subanalysis of the SACURA trial.

Journal of Clinical Oncology2017-05-20

A randomized phase III trial of 1-year adjuvant chemotherapy with oral tegafur-uracil (UFT) vs. surgery alone in stage II colon cancer: SACURA trial.

Journal of Clinical Oncology2016-05-205 citations

Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer.

2012-07-077 citations